L-Arginine deprivation impairs Leishmania major-specific T-cell responses

European Journal of Immunology

Volumn 39, Issue 8, 2009, Pages 2161-2172

  Munder, Markus ^a   Choi, Beak San ^b   Rogers, Matthew ^b   Kropf, Pascale ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell activation; Cell proliferation; T cells; Th1 Th2 cells

Indexed keywords

AMINO ACID; ARGINASE; ARGININE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXPERIMENTAL INFECTION; EXTRACELLULAR FLUID; FEMALE; HELPER CELL; IMMUNOREGULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CBA MOUSE; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; HOST PARASITE INTERACTION; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PHYSIOLOGY; SKIN LEISHMANIASIS;

ANIMALS; ARGINASE; ARGININE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HOST-PARASITE INTERACTIONS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; T-LYMPHOCYTES;

EID: 70249139506     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839041     Document Type: Article

References (45)

1. Popovic, P. J., Zeh, H. J., III and Ochoa, J. B., Arginine and immunity. J. Nutr. 2007. 137: 1681S-1686S.
2. Morris, S. M., Jr., Arginine metabolism: boundaries of our knowledge. J. Nutr. 2007. 137: 1602S-1609S.
3. Munder, M., Eichmann, K., Moran, J. M., Centeno, F., Soler, G. and Modolell, M., Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999. 163: 3771-3777. (Pubitemid 29450901)
4. Jost, M. M., Ninci, E., Meder, B., Kempf, C., van Royen, N., Hua, J., Berger, B., et al., Divergent effects of GM-CSF and TGF-b1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expresssion and matrix-metalloproteinase-12: a potential role during arteriogenesis. FASEB J. 2003. 17: 2281-2283.
5. Martin, L., Comalada, M., Marti, L., Closs, E. I., MacLeod, C. L., Martin del Rio, R., Zorzano, A. et al., Granulocyte-macrophage colony-stimulating factor increases L-arginine transport through the induction of CAT2 in bone marrow-derived macrophages. Am. J. Physiol. Cell Physiol. 2006. 290: C1364-C1372.
6. Corraliza, I. M., Soler, G., Eichmann, K. and Modolell, M., Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 1995. 206: 667-673.
7. Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J. and Ochoa, A. C., Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 2005. 202: 931-939.
8. Bernard, A. C., Fitzpatrick, E. A., Maley, M. E., Gellin, G. L., Tsuei, B. J., Arden, W. A., Boulanger, B. R. et al., Beta adrenoceptor regulation of macrophage arginase activity. Surgery 2000. 127: 412-418.
9. Rodriguez, P. C. and Ochoa, A. C., Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 2008. 222: 180-191.
10. Bronte, V. and Zanovello, P., Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005. 5: 641-654.
11. Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J. M., Luckner, C. et al., Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005. 105: 2549-2556. (Pubitemid 40387058)
12. Munder, M., Schneider, H., Luckner, C., Giese, T., Langhans, C. D., Fuentes, J., Kropf, P. et al., Suppression of T cell functions by human granulocyte arginase. Blood 2006. 108: 1627-1634. (Pubitemid 44316131)
13. Kropf, P., Baud, D., Marshall, S. E., Munder, M., Mosley, A., Fuentes, J. M., Bangham, C. R. et al., Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 2007. 37: 935-945.
14. Etges, R. and Müller, I., Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions. J. Mol. Med. 1998. 76: 372-390.
15. Sacks, D. L. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
16. Munder, M., Eichmann, K. and Modolell, M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 5347-5354. (Pubitemid 28267823)
17. Wei, X., Charles, I. G., Smith, A., Ure, J., Feng, G., Huang, F., Xu, D., et al., Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995. 375: 408-411.
18. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2001. 2: 907-916.
19. Kropf, P., Fuentes, J. M., Fahnrich, E., Arpa, L., Herath, S., Weber, V., Soler, G. et al., Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005. 19: 1000-1002. (Pubitemid 40827731)
20. Zea, A. H., Rodriguez, P. C., Culotta, K. S., Hernandez, C. P., DeSalvo, J., Ochoa, J. B., Park, H. J. et al., L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol. 2004. 232: 21-31. (Pubitemid 40732717)
21. Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J. Q. D. G., Ochoa, J. B. and Ochoa, A. C., L-arginine consumption by macrophages modulates the expression of CD3z chain in T lymphocytes. J. Immunol. 2003. 171: 1232-1239. (Pubitemid 36900052)
22. Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B. and Ochoa, A. C., Regulation of T cell receptor CD3ζ chain expression by L-arginine. J. Biol. Chem. 2002. 277: 21123-21129.
23. Choi, B. S., Martinez-Falero, I. C., Corset, C., Munder, M., Modolell, M., Muller, I. and Kropf, P., Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages. J. Leukoc. Biol. 2009. 85: 268-277.
24. Kropf, P., Herath, S., Tewari, R., Syed, N., Klemenz, R. and Müller, I., Identification of two distinct subpopulations of Leishmania major specific T helper 2 cells. Infect. Immun. 2002. 70: 5512-5520.
25. Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W., Davey, D. F., Flynn, B. J., Hoff, S. T. et al., Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007. 13: 843-850.
26. Titus, R. G., Milon, G., Marchal, G., Vassalli, P., Cerottini, J. C. and Louis, J. A., Involvement of specific Lyt2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 1987. 17: 1429-1433.
27. Müller, I., Pedrazzini, T., Kropf, P., Louis, J. and Milon, G., Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+T cells. Int. Immunol. 1991. 3: 587-597.
28. Belkaid, Y., von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., Udey, M. C. and Sacks, D., CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 2002. 3992-4000. (Pubitemid 34298404)
29. Herath, S., Kropf, P. and Müller, I., Cross-talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-g production by CD4+ T cells. Parasite Immunol. 2003. 559-567.
30. Iniesta, V., Gomez-Nieto, L. C. and Corraliza, I., The inhibition of Arginase by Nw-Hydroxy-L-Arginine controls the growths of Leishmania inside macrophages. J. Exp. Med. 2001. 193: 777-783.
31. Iniesta, V., Carcelen, J., Molano, I., Peixoto, P. M., Redondo, E., Parra, P., Mangas, M. et al., Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005. 73: 6085-6090.
32. Zabaleta, J., McGee, D. J., Zea, A. H., Hernandez, C. P., Rodriguez, P. C., Sierra, R. A., Correa, P. and Ochoa, A. C., Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J. Immunol. 2004. 173: 586-593. (Pubitemid 38797387)
33. Rodriguez, P. C., Quiceno, D. G. and Ochoa, A. C., L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007. 109: 1568-1573.
34. Vercelli, D., Arginase: marker, effector, or candidate gene for asthma? J. Clin. Invest. 2003. 111: 1815-1817.
35. Bruch-Gerharz, D., Schnorr, O., Suschek, C., Beck, K.-F., Pfeilschnifter, J., Ruzicka, T. and Kolb-Bachofen, V., Arginase 1 overexpression in psoriasis. Am. J. Pathol. 2003. 162: 203-211.
36. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J. and Wynn, T. A., Differential regulation of nitric oxide synthase-2 and arginase-1 by type1/type2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 2001. 167: 6533-6544. (Pubitemid 33081589)
37. Vincendeau, P., Gobert, A. P., Daulouede, S., Moynet, D. and Mossalayi, M. D., Arginases in parasitic diseases. Trends Parasitol. 2003. 19: 9-12.
38. Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. et al., Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005. 65: 3044-3048. (Pubitemid 40524582)
39. Zea, A. H., Culotta, K. S., Ali, J., Mason, C., Park, H. J., Zabaleta, J., Garcia, L. F. and Ochoa, A. C., Decreased Expression of CD3 zeta and Nuclear Transcription Factor kappa B in Patients with Pulmonary Tuberculosis: Potential Mechanisms and Reversibility with Treatment. J. Infect. Dis. 2006. 194: 1385-1393.
40. Kusmartsev, S., Nefedova, Y., Yoder, D. and Gabrilovich, D. I., Antigen-specific inhibition of CD8+ T cells response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 2004. 172: 989-999. (Pubitemid 38113758)
41. Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A. et al., Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004. 64: 5839-5849. (Pubitemid 39095585)
42. Iniesta, V., Gomez-Nieto, L. C., Molano, I., Mohedano, A., Carcelen, J., Miron, C., Alonso, C. and Corraliza, I., Arginase I induction in macrophages, triggered by Th2-type cytokines supports the growth of intracellular Leishmania parasites. Parasite Immunol. 2002. 24: 113-118. (Pubitemid 34451222)
43. Bretscher, P. A., Wei, G., Menon, J. N. and Bielefeldt-Ohmann, H., Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992. 257: 539-542.
44. Menon, J. N. and Bretscher, P. A., Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur. J. Immunol. 1998. 28: 4020-4028.
45. Kropf, P., Brunson, K., Etges, R. and Müller, I., The Leishmaniasis Model Immunology of Infection, 1st Edn. Academic Press, San Diego 1998, pp. 419-458.